[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-333959-105":3,"detail-sidebar-cat-0-en-105":80,"doc-detail-333959-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":73,"head_meta":75,"extra_data":77,"updated_unix":79},105,"en","adamts4-exacerbates-lung-cancer-progression-via-regulating-c-myc-protein-stability-and-activating-mapk-signaling-pathway","ADAMTS4 exacerbates lung cancer progression via regulating c-Myc protein stability and activating MAPK signaling pathway","","Lung cancer causes high mortality worldwide with poor prognosis, and the extracellular-matrix regulator ADAMTS4 has been connected to tumor progression, though its lung-cancer role is unclear. ADAMTS4 levels were assessed in human lung cancer samples, and its effects on malignant phenotypes were tested in vitro and in vivo. Mechanistic studies used ubiquitination-related assays to define how ADAMTS4 drives progression.",{"@graph":14,"@context":72},[15,34,55],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/adamts4-exacerbates-lung-cancer-progression-via-regulating-c-myc-protein-stability-and-activating-mapk-signaling-pathway/333959/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/adamts4-exacerbates-lung-cancer-progression-via-regulating-c-myc-protein-stability-and-activating-mapk-signaling-pathway/333959.png","ImageObject",300,407,{"name":42,"@type":43},"Rowan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":33},"InteractionCounter",{"@type":54},"ViewAction",{"@type":56,"mainEntity":57},"FAQPage",[58,64,68],{"name":59,"@type":60,"acceptedAnswer":61},"How was ADAMTS4 involved in lung cancer progression evaluated in this study?","Question",{"text":62,"@type":63},"ADAMTS4 expression was measured in human lung cancer samples using immunohistochemical staining, and its functional effects were tested in vitro and in vivo using lung cancer models.","Answer",{"name":65,"@type":60,"acceptedAnswer":66},"What did the study find about ADAMTS4 expression and patient prognosis?",{"text":67,"@type":63},"ADAMTS4 was significantly upregulated at the protein level in lung cancer tissues versus para-carcinoma tissues, and higher ADAMTS4 expression correlated with worse prognosis.",{"name":69,"@type":60,"acceptedAnswer":70},"What mechanism links ADAMTS4 to lung cancer growth and signaling?",{"text":71,"@type":63},"The study suggests ADAMTS4 stabilizes c-Myc by inhibiting its ubiquitination, promoting tumor growth and angiogenesis-related effects, and it also activates the MAPK signaling pathway.","https://schema.org",{"og:url":32,"og:type":74,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":76,"canonical":32},"index,follow",{"doc_id":78,"site_id":7},333959,1790854122,{"code":4,"msg":81,"data":82},"success",[83,87,91,95,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":84,"show_sort_weight":85,"slug":86},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":88,"show_sort_weight":89,"slug":90},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":92,"show_sort_weight":93,"slug":94},"Exam",70,"exam",{"id":96,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},5,"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":96,"slug":129},19,"General","general",{"code":4,"msg":81,"data":131},{"doc_id":78,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":33,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","Zhai et al. Biology Direct (2024) 19:94 [https://doi.org/10.1186/s13062-024-00512-y](https://doi.org/10.1186/s13062-024-00512-y)  \nBiology Direct  \n RESEARCH Open Access  \nADAMTS4 exacerbates lung cancer  \nprogression via regulating c-Myc protein  \nstability and activating MAPK signaling pathway  \nWei Zhai1†, WenshengYang2†, Jing Ge3†, Xuelian Xiao4, Kang Wu5, Kelin She6, Yu Zhou7, Yi Kong7, Lin Wu7, Shiya Luo5 and Xingxiang Pu7*  \nAbstract  \nBackground Lung cancer is one of the most frequent cancers and the leading cause of cancer-related deaths worldwide with poor prognosis. A disintegrin and metalloproteinase with thrombospondin motifs 4 (ADAMTS4) is crucial in the regulation of the extracellular matrix (ECM), impacting its formation, homeostasis and remodeling, and has been linked to cancer progression. However, the specific involvement of ADAMTS4 in the development of lung cancer remains unclear.  \nMethods ADAMTS4 expression was identified in human lung cancer samples by immunohistochemical (IHC) staining and the correlation of ADAMTS4 with clinical outcome was determined. The functional impact of ADAMTS4 on malignant phenotypes of lung cancer cells was explored both in vitro and in vivo. The mechanisms underlying ADAMTS4-mediated lung cancer progression were explored by ubiquitination-related assays.  \nResults Our study revealed a significant upregulation of ADAMTS4 at the protein level in lung cancer tissues compared to para-carcinoma normal tissues. High ADAMTS4 expression inversely correlated with the prognosis of lung cancer patients. Knockdown of ADAMTS4 inhibited the proliferation and migration of lung cancer cells, as well as the tubule formation of HUVECs, while ADAMTS4 overexpression exerted opposite effects. Mechanistically, we found that ADAMTS4 stabilized c-Myc by inhibiting its ubiquitination, thereby promoting the in vitro and in vivo growth of lung cancer cells and inducing HUVECs tubule formation in lung cancer. In addition, our results suggested that ADAMTS4 overexpression activated MAPK signaling pathway.  \nConclusions We highlighted the promoting role of ADAMTS4 in lung cancer progression and proposed ADAMTS4 as a promising therapeutic target for lung cancer patients.  \nKeywords ADAMTS4, Lung cancer, c-Myc, Ubiquitination, Angiogenesis, MAPK signaling  \n†Wei Zhai, WenshengYang and Jing Ge have contributed equally to this work and share first authorship.  \n*Correspondence: Xingxiang Pu[puxingxiang@hnca.org.cn](puxingxiang@hnca.org.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/.)[.](http://creativecommons.org/licenses/by-nc-nd/4.0/.)  \nZhai et al. Biology Direct (2024) 19:94  \nIntroduction  \nLung cancer stands as one of the most frequent malignancies worldwide, responsible for a staggering number of cancer-related deaths, with nearly 2 million new cases reported annually [1] . It is categorized int","cbCaiioRpgYH7OQa","https://ap.wps.com/l/cbCaiioRpgYH7OQa","pdf",6429330,17,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"How was ADAMTS4 involved in lung cancer progression evaluated in this study?\",\"answer\":\"ADAMTS4 expression was measured in human lung cancer samples using immunohistochemical staining, and its functional effects were tested in vitro and in vivo using lung cancer models.\"},{\"question\":\"What did the study find about ADAMTS4 expression and patient prognosis?\",\"answer\":\"ADAMTS4 was significantly upregulated at the protein level in lung cancer tissues versus para-carcinoma tissues, and higher ADAMTS4 expression correlated with worse prognosis.\"},{\"question\":\"What mechanism links ADAMTS4 to lung cancer growth and signaling?\",\"answer\":\"The study suggests ADAMTS4 stabilizes c-Myc by inhibiting its ubiquitination, promoting tumor growth and angiogenesis-related effects, and it also activates the MAPK signaling pathway.\"}]","ADAMTS4 exacerbates lung cancer progression via regulating c-Myc protein stability and activating MAPK signaling pathway | PDF",1790004779,43]